Jennifer R. Brown, MD, PhD
2 clinical trials · Sponsor
◉ Watch Jennifer R. Brown, MD, PhD
| Record | Firm | Date |
|---|---|---|
| Roginolisib (IOA-244) With Venetoclax and Rituximab for Refractory/Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT06644183) | Jennifer R. Brown, MD, PhD | 2025-03-19 |
| Acalabrutinib, Umbralisib, and Ublituximab (AU2) In Relapsed and Untreated CLL (NCT04624633) | Jennifer R. Brown, MD, PhD | 2020-12-15 |
Track Jennifer R. Brown, MD, PhD automatically
Every clearance here is in the API, with alerts when new ones post.